Neuroform Atlas stent-assisted coiling of ruptured wide-necked anterior communicating artery aneurysms

Hongping Wang, S. Jack Hu, Jing Xu, Jian Pei, Yunhe Gao, Bing Tian, Dayong Wang, Yu Zheng, Xiang XuFrontiers in Neurology 2025 · DOI

TL;DR

This study evaluates the safety and efficacy of the Neuroform Atlas stent for treating ruptured, wide-necked aneurysms in the anterior communicating artery (ACoA)—one of the most challenging anatomical sites for endovascular surgery. The researchers found that the stent’s low-profile design allowed for a 100% technical success rate and favorable clinical outcomes in 96.7% of patients, suggesting it is a robust tool for complex neurovascular emergencies.

What Problem Does This Paper Address?

Anterior communicating artery (ACoA) aneurysms are the most common type of intracranial aneurysm and a frequent site of life-threatening ruptures. When an aneurysm is "wide-necked" (neck >4mm or a dome-to-neck ratio <2:1), traditional coiling—where a surgeon fills the "bulge" with platinum wire—is risky. The coils can easily herniate out of the aneurysm and block the parent artery, leading to a stroke.

Treating these specifically after a rupture is even harder. The surrounding vessels are often small, tortuous, and potentially narrowed by vasospasm or compressed by a hematoma. While Stent-Assisted Coiling (SAC) provides a "scaffold" to keep coils in place, many older stents were too bulky or stiff to navigate the tiny, fragile vessels of the ACoA complex safely. This paper investigates whether the newer Neuroform Atlas stent can bridge this gap in emergency settings.

Methods

The authors conducted a retrospective analysis of 30 patients treated at Tangshan Workers’ Hospital (China) between 2020 and 2022. All patients had ruptured wide-necked ACoA aneurysms confirmed via Digital Subtraction Angiography (DSA).

The core intervention was SAC using the Neuroform Atlas stent, a self-expanding nitinol device. The study highlighted two primary deployment techniques:

  1. Double Microcatheter Method (23 patients): Used for complex topologies to ensure stable coil packing and prevent compaction.
  2. Single Microcatheter Method (7 patients): Utilizing the stent’s "cross-cell" design, where the coiling microcatheter passes directly through the stent’s mesh into the aneurysm.

Outcomes were measured using the Raymond-Roy (RR) occlusion grading (how well the aneurysm was blocked) and the modified Rankin Scale (mRS) (the patient’s functional recovery).

Datasets

As a clinical research paper, the "dataset" consists of a specific patient cohort rather than a public machine learning benchmark:

  • Cohort Size: 30 patients (18 men, 12 women).
  • Mean Age: 55.37 years.
  • Clinical Baseline: Hunt-Hess grades (severity of subarachnoid hemorrhage) ranged from 0 to 4.
  • Follow-up: Clinical follow-up via interviews or clinic visits; radiographic follow-up via DSA at 6 months for a subset of patients.

Key Insights and Ideas

  • The "Smart Cell" Advantage: The Neuroform Atlas features a hybrid open-cell/closed-cell design. This provides high "conformability" (the ability to hug the vessel wall even in tight curves) while maintaining enough structural integrity to support the coils.
  • Low-Profile Delivery: The stent is delivered via a very small microcatheter (0.0165–0.017 inches). This is crucial for ACoA work, where the parent vessels (A1/A2 segments) are often too small for bulkier delivery systems.
  • Single-Catheter Feasibility: The researchers noted that the stent's mesh is designed to allow a coiling microcatheter to pass through it easily. This simplifies the procedure in tiny vessels where there isn't enough physical space to navigate two separate catheters side-by-side.
  • Tirofiban as a Safety Net: To manage the high risk of thrombosis (clotting) associated with placing a metal stent in a ruptured environment, the team used progressive administration of tirofiban (a glycoprotein IIb/IIIa inhibitor), which successfully resolved the one case of acute in-stent thrombosis observed.

Key Results

  • Technical Success: 100% (30/30) successful stent placement with good expansion.
  • Occlusion Rates: Of the 19 patients with immediate post-procedural imaging data, 94.7% (18/19) achieved Grade I (complete) occlusion.
  • Clinical Outcomes: 96.7% (29/30) of patients achieved a favorable outcome (mRS ≤ 2) at follow-up. Only one patient had a poor prognosis (mRS 3).
  • Complications: The overall procedure-related complication rate was 10% (3 patients). This included two cases of intraoperative hemorrhage (successfully managed by rapid coiling) and one case of thrombosis (resolved with medication). No procedure-related deaths occurred.

Limitations and Future Work

The authors acknowledge several constraints:

  • Sample Size: 30 patients is a small cohort for definitive safety conclusions.
  • Study Design: Being a retrospective study without a control group (e.g., comparing against other stents or surgical clipping) limits the ability to claim superiority.
  • Follow-up Duration: The follow-up period was relatively short (less than 2 years). Long-term data is needed to ensure the "durability" of the repair—specifically, checking for delayed in-stent stenosis or aneurysm recurrence.
  • Selection Bias: As a single-center study, the results may reflect the specific expertise of the local surgical team.

The authors call for prospective, multicenter trials with larger populations to further validate these findings.

Summary updated

Abstract

One of the most crucial methods for treating wide-neck anterior communicating artery aneurysms is endovascular therapy. However, because of the small arterial diameter and volume with hematoma, endovascular embolization procedures for the treatment of burst wide-necked ACoA aneurysms are difficult. Few studies have been conducted to evaluate the Neuroform Atlas stent's safety and effectiveness in treating wide-necked anterior communicating artery aneurysms, despite the fact that it has been frequently utilized to treat wide-necked aneurysms since its 2020 debut in China. Thus, this article's goal is to examine the effectiveness and safety of Neuroform Atlas stent-assisted coiling in the management of anterior communicating artery burst wide-necked aneurysms. From August 2020 to June 2022, Neuroform Atlas stents were used to treat 30 patients with aneurysms of the ruptured wide-necked anterior connecting arteries. Neuroform Atlas stents were successfully and satisfactorily positioned in each of the 30 patients. Three patients had postoperative complications. Twenty-nine patients (96.7%) achieved an mRS score of ≤2, demonstrating satisfactory clinical outcomes, while one patient (3.3%) had an mRS score of 3, indicating poor prognosis. This pilot research shows that coiling ruptured wide-necked aneurysms of the anterior communicating artery with the use of a Neuroform Atlas stent is safe and effective.
BibTeX
@inproceedings{wang2025neuroform,
  author = {Hongping Wang and S. Jack Hu and Jing Xu and Jian Pei and Yunhe Gao and Bing Tian and Dayong Wang and Yu Zheng and Xiang Xu},
  title = {{Neuroform Atlas stent-assisted coiling of ruptured wide-necked anterior communicating artery aneurysms}},
  booktitle = {Frontiers in Neurology},
  year = {2025},
  doi = {10.3389/fneur.2025.1674012},
}
Figure